Lack of association between the CDH1 polymorphism and gastric cancer susceptibility: A meta-analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jiang, Benchun ^a   Zhu, Ke ^a   Shao, Hua ^a   Bao, Chenhui ^a   Ou, Jinlei ^a   Sun, Wei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CDH1 PROTEIN, HUMAN;

GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; PATHOLOGY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR;

CADHERINS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 84954219778     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07891     Document Type: Article

References (46)

1. Dicken, B. J. et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 241, 27-39 (2005).
2. Nardone, G. Review article: molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther Suppl. 2, 75-81 (2003).
3. Takezaki, T. et al. Comparative study of lifestyles of residents in high and low risk areas for gastric cancer in Jiangsu Province, China; with special reference to allium vegetables. J Epidemiol. 9, 297-305 (1999).
4. Kobayashi, M., Tsubono, Y., Sasazuki, S., Sasaki, S., Tsugane, S. Vegetables, fruit and risk of gastric cancer in Japan: A 10-year follow-up of the JPHC Study Cohort I. Int J Cancer. 102, 39-44 (2002).
5. Galanis, D. J., Lee, J., Kolonel, L. N. The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer. 79, 1840-1841 (1997).
6. Zhang, Z. F. et al. Helicobacter pylori infection on the risk of stomach cancer and chronic atrophic gastritis. Cancer Detect Prev. 23, 357-367 (1999).
7. Setiawan, V. W. et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: A case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev. 9, 73-80 (2000).
8. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 251, 1451-1455 (1991).
9. Takeichi, M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem. 59, 237-252 (1990).
10. Grunwald, G. B. The structural and functional analysis of cadherin calciumdependent cell adhesion molecules. Curr Opin Cell Biol. 5, 797-805 (1993).
11. van Roy, F.& Berx, G. The cell-cell adhesion molecule Ecadherin. Cell Mol Life Sci. 65, 3756-3788 (2008).
12. Perl, A. K.,Wilgenbus, P., Dahl, U., Semb, H., Christofori, G. A causal role for Ecadherin in the transition from adenoma to carcinoma. Nature. 392, 190-193 (1998).
13. Li, L. C. et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 60, 873-876 (2002).
14. Kiemeney, L. A. et al. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer. Eur J Cancer. 42, 3219-3227 (2006).
15. Wang, G. Y., Lu, C. Q., Zhang, R. M., Hu, X. H., Luo, Z. W. The E-cadherin gene polymorphism 160 C-.A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol. 167, 7-14 (2008).
16. Humar, B. et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene. 21, 8192-8195 (2002).
17. Pharoah, P. D. et al. CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer. Int J Cancer. 101, 196-197 (2002).
18. Wu, M. S. et al. Association of the-160 CRA promoter polymorphism of Ecadherin gene with gastric carcinoma risk. Cancer. 94, 1443-1448 (2002).
19. Park, W. S. et al. A Single Nucleotide Polymorphism in the E-cadherin Gene Promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci. 18, 501-504 (2003).
20. Kuraoka, K. et al. Correlation of a single nucleotide polymorphism in the Ecadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol. 23, 421-427 (2003).
21. Shin, Y. et al. The E-cadherin-347 G-.GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis. 25, 895-899 (2004).
22. Lu, Y. et al. E-cadherin gene C-160A promoter polymorphism and risk of noncardia gastric cancer in a Chinese population. World J Gastroenterol. 11, 56-60 (2005).
23. Song, C. G. et al. Association of-160 (CRA) polymorphism in CDH1 gene with gastric cancer risk in Fujian Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 22, 557-559 (2005).
24. Zhang, X. F. et al. Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Ai Zheng. 24, 513-519 (2005).
25. Cattaneo, F. et al. Functional analysis and case-control study of-160 C/A polymorphism in the E-cadherin gene promoter: association with cancer risk. Anticancer Res. 26, 4627-4632 (2006).
26. Medina-Franco, H., Ramos-De laMedina, A., Vizcaino, G.& Medina-Franco, J. L. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population. Ann Surg Oncol. 14, 2246-2249 (2007).
27. Yamada, H. et al.Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand J Gastroenterol. 42, 1479-1485 (2007).
28. Jenab, M. et al. CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer. 44, 774-780 (2008).
29. Zhang, B. et al. Genetic polymorphisms of the E-cadherin promoter and risk of sporadic gastric carcinoma in Chinese populations. Cancer Epidemiol Biomarkers Prev. 17, 2402-2408 (2008).
30. Zhang, X. F. et al. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus. 21, 21-29 (2008).
31. Corso, G. et al. CDH1 C-160A promoter polymorphism and gastric cancer risk. Eur J Cancer Prev. 18, 46-49 (2009).
32. Al-Moundhri, M. S. et al. Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J Gastroenterol. 16, 3432-3436 (2010).
33. Borges Bdo, N. et al. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil. Anticancer Res. 30, 2225-2233 (2010).
34. Zhan, Z. et al. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population. Mol Biol Rep. 39, 8107-8113 (2012).
35. Chu, C. M. et al. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis. World J Surg Oncol. 12, 80 (2014).
36. Christofori, G., Semb, H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 24, 73-76 (1999).
37. Abnet, C. C. et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 42, 764-767 (2010).
38. Wang, L. D. et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet. 42, 759-763 (2010).
39. Shi, Y. et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 43, 1215-1218 (2011).
40. Jin, G. et al. Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese. Am J Hum Genet. 91, 928-934 (2012).
41. Saeki, N., Ono, H., Sakamoto, H., Yoshida, T. Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study. Cancer Sci. 104, 1-8 (2013).
42. Saeki, N., Sakamoto, H., Yoshida, T. Mucin 1 gene (MUC1) and gastric-cancer susceptibility. Int J Mol Sci. 15, 7958-7973 (2014).
43. Gao, L., Nieters, A., Brenner, H. Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment Pharmacol Ther. 28, 565-573 (2008).
44. Li, Y. L., Tian, Z., Zhang, J. B., Fu, B. Y. CDH1 promoter polymorphism and stomach cancer susceptibility. Mol Biol Rep. 39, 1283-1286 (2012).
45. Zheng, R. L., Zhang, H., Jiang, W. L. Tumor necrosis factor-alpha 308G. A polymorphism and risk of rheumatic heart disease: a meta-analysis. Sci Rep. 4, 4731 (2014).
46. Thakkinstian, A., D'Este, C., Eisman, J., Nguyen, T., Attia, J. Meta-analysis of molecular association studies: vitamin Dreceptor gene polymorphisms and BMD as a case study. J Bone Miner Res. 19, 419-428 (2004).